All articles by GlobalData 

  1. Characterising Eastern China’s pharmaceutical manufacturing market: Shandong and Jiangsu

    The following article is the second of two articles covering Eastern China, specifically Shandong and Jiangsu (eastern provinces north of the…
    Read More…

    13 Jun
  2. Stroke: a growing burden across eight major markets to 2027

    A stroke occurs when blood supply to the brain is interrupted by a clot or when a blood vessel bursts….
    Read More…

    12 Jun
  3. Fine-tuning checkpoint inhibitor use in triple-negative breast cancer

    This year’s American Society of Clinical Oncology (ASCO 2019) meeting in Chicago was a testament to the widespread use of…
    Read More…

    12 Jun
  4. The microbiome in IBD: multiomics analysis may help clarify an elusive mechanism of action

    On 29 May, a treasure trove of data from the US National Institutes of Health’s (NIH) Human Microbiome Project (HMP)…
    Read More…

    11 Jun
  5. Approval for Piqray, the first PI3K inhibitor in the treatment of breast cancer

    On 24 May, the US Food and Drug Administration (FDA) approved Piqray (alpelisib), a first-in-class phosphoinositide 3-kinase (PI3K) inhibitor for…
    Read More…

    11 Jun
  6. Premature birth rate remains highest in the US

    In 2015, the US had the highest proportion of live premature births, defined as a gestational age of fewer than…
    Read More…

    11 Jun
  7. Novel HER2 blockade treatments continue to show promise in third-line setting for metastatic breast cancer

    During this year’s American Society of Clinical Oncology (ASCO 2019) meeting in Chicago, two new third-line treatment options were discussed,…
    Read More…

    10 Jun
  8. Takeda’s Ninlaro fails in Phase III trial for treatment of amyloidosis

    Takeda has announced it will be discontinuing its Phase III trial investigating its multiple myeloma drug Ninlaro (ixazomib) for the…
    Read More…

    10 Jun
  9. Will oral therapies be eclipsed by parenteral delivery in the treatment of restless legs syndrome?

    Restless legs syndrome (RLS) is a neurological movement disorder that affects more than 37 million people worldwide. The disorder is…
    Read More…

    10 Jun
  10. What role is there for cannabis use in cancer care?

    With cannabis slowly becoming legalised across North America, physicians meeting recently in Chicago at the American Society of Clinical Oncology…
    Read More…

    10 Jun
Close
Close
Close

Go Top